Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study

BACKGROUND: Previous studies have confirmed that systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) can predict the prognosis and chemotherapy efficacy of various malignant tumors. However, to the best of our knowledge, no study investigated the SII combined with PNI sco...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Ping’an, Guo, Honghai, Sun, Chenyu, Yang, Peigang, Kim, Na Hyun, Tian, Yuan, Liu, Yang, Liu, Pengpeng, Li, Yong, Zhao, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919583/
https://www.ncbi.nlm.nih.gov/pubmed/35287591
http://dx.doi.org/10.1186/s12876-022-02199-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919583/
https://www.ncbi.nlm.nih.gov/pubmed/35287591
http://dx.doi.org/10.1186/s12876-022-02199-9

Ejemplares similares